August 23, 2021
August 23, 2021
Enteris recognized for the third consecutive year in the Pharmaceutical Company category Boonton, NJ, August 23, 2021 — Enteris BioPharma, Inc., a biotechnology company developing innovative […]
June 15, 2021
June 15, 2021
On June 29 at 1pm ET, Co-Hosts Josh Stephens and Angela Consalvo Will Share Knowledge and Expertise on Selecting CDMOs for HPAPI and SOD Manufacturing […]
June 11, 2021
June 11, 2021
Third milestone payment related to the development of Oral KORSUVA™ Dallas, TX, June 11, 2021 — SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty […]
June 7, 2021
June 7, 2021
Enteris to Seek Deeper Development and Manufacturing Opportunities BOONTON, N.J., June 7, 2021 — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on […]
April 30, 2021
April 30, 2021
CDMO Business Driven by Custom Solutions from Bench to Market for the Development and Manufacture of Difficult to Formulate Drugs and Highly Potent Compounds BOONTON, […]
March 16, 2021
March 16, 2021
BOONTON, N.J., March 16, 2021 — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of […]
January 12, 2021
January 12, 2021
Boonton, NJ – January 12, 2021 – Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned […]
KNOWLEDGE CENTER
Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.
LEARN MOREKNOWLEDGE CENTER
Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.
LEARN MORE
